speb/financial-data huggingface dataset:
Financial ratios for AGNT — annual report dated 2025-12-31
Total revenue: 4772311000
Gross profit: 333578000
Operating income: -21466000
Net income: -22714000
Capital expenditures: 9569000
Operating cash flow: 118611000
Depreciation & amortization: 9562000
Net tangible assets: 220486000
Owner earnings: -22721000
Return on net tangible assets (%): -10.304962673367017
Buffett classification: The Gruesome
Stock price: 8.89
Shares outstanding: 164323924
Book value: 242779000
P/B ratio: 6.017158338900812
Market cap (USD): 1460839684.3600001
Debt to equity: 0
Current ratio: 1.526622300339007
Quick ratio: 1.526622300339007
COGS to revenue (%): 93.01013701747435
R&D to revenue (%): 1.4587900914253074
SG&A to revenue (%): 5.980875932017004
Free cash flow (dilution-adjusted): -34594000
Buyback yield (%): 3.8470340449863265
Retained earnings: -121622000
Receivables turnover: 43.847838071261876
Capitalized R&D asset: 128250450
ROCI (R&D-adjusted, %): -3.8533329362399673
Rosenberg metric: -0.15154171393214397
FCF margin (%): -0.7248898908725773
Revenue growth (%): 4.480159696230377
Rule of 40 score: 3.7552698053577998
Financial ratios for AKW.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.40909090909091
Shares outstanding: 26544196
Market cap (USD): 568287105.2727273
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AKW.PA — annual report dated 2022-12-31
Total revenue: 1053659574.4680852
Gross profit: 543319148.9361702
Operating income: 41090425.5319149
Net income: 11817021.276595745
Capital expenditures: 33496808.5106383
Operating cash flow: 51997872.340425536
Depreciation & amortization: 42260638.29787234
Net tangible assets: 595521276.5957447
Owner earnings: 20580851.06382979
Return on net tangible assets (%): 3.4559388342056843
Capex to operating income (%): 81.51974110032363
Buffett classification: The Gruesome
Stock price: 16.4468085106383
P/E ratio: 36.94393861721282
Shares outstanding: 26544196
Book value: 635752127.6595745
P/B ratio: 0.6866942156969379
Market cap (USD): 436567308.6808511
Debt to equity: 0.08840090561188206
Current ratio: 2.7603338592294775
Quick ratio: 1.9828388213140618
Effective tax rate (%): 55.41737972998669
Interest coverage ratio: 27.067274001401543
COGS to revenue (%): 48.43503897257785
Free cash flow (dilution-adjusted): 9070212.765957447
Buyback yield (%): 0
Retained earnings: 11787234.042553192
Inventory turnover: 3.1401453164888395
Receivables turnover: 6.363332648026316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7716963482533234
FCF margin (%): 0.8608295303097613
Rule of 40 score: 0.8608295303097613
Financial ratios for AKW.PA — annual report dated 2023-12-31
Total revenue: 1184586666.6666667
Gross profit: 638155555.5555556
Operating income: 67824444.44444445
Net income: 39691111.11111111
Capital expenditures: 62884444.44444444
Operating cash flow: 71004444.44444445
Depreciation & amortization: 42887777.777777776
Net tangible assets: 637262222.2222222
Owner earnings: 19694444.444444455
Return on net tangible assets (%): 3.0904773196451503
Capex to operating income (%): 92.71649028537728
Buffett classification: The Gruesome
Stock price: 16.288888888888888
P/E ratio: 10.893508576227534
Shares outstanding: 26544196
Book value: 678055555.5555556
P/B ratio: 0.6376696654813601
Market cap (USD): 432375459.2888889
Debt to equity: 0.07619664072101597
Current ratio: 2.7935165180699673
Quick ratio: 1.9138494152491656
Effective tax rate (%): 26.259560519606655
Interest coverage ratio: 36.11952662721894
COGS to revenue (%): 46.12841985202527
Free cash flow (dilution-adjusted): 7076666.666666666
Buyback yield (%): 0
Retained earnings: 39691111.11111111
Inventory turnover: 2.8353137197248786
Receivables turnover: 6.4134558120228835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.901312988141694
FCF margin (%): 0.5973954346945206
Revenue growth (%): 12.425938640065695
Rule of 40 score: 13.023334074760216
Financial ratios for AKW.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 592509375
Buffett classification: The Gruesome
Stock price: 7.802083333333334
Shares outstanding: 26544196
Book value: 632442708.3333333
P/B ratio: 0.3274605374992795
Market cap (USD): 207100029.20833334
Debt to equity: 0.028106959622495455
Current ratio: 3.521267799724391
Quick ratio: 2.520398572488604
Buyback yield (%): 0
Retained earnings: 25197916.666666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AKW.PA — annual report dated 2024-12-31
Total revenue: 1030202083.3333334
Gross profit: 555193750
Operating income: 39995833.333333336
Net income: 25271875
Capital expenditures: 41872916.66666667
Operating cash flow: 100560416.66666667
Depreciation & amortization: 40905208.333333336
Net tangible assets: 592509375
Owner earnings: 24304166.666666664
Return on net tangible assets (%): 4.101904154118517
Capex to operating income (%): 104.6931972080425
Buffett classification: The Gruesome
Stock price: 7.802083333333334
P/E ratio: 8.19488182844895
Shares outstanding: 26544196
Book value: 632442708.3333333
P/B ratio: 0.3274605374992795
Market cap (USD): 207100029.20833334
Debt to equity: 0.028106959622495455
Current ratio: 3.521267799724391
Quick ratio: 2.520398572488604
Effective tax rate (%): 40.48064994770256
Interest coverage ratio: 24.04257983719474
COGS to revenue (%): 46.108267593129995
Free cash flow (dilution-adjusted): 51695833.333333336
Buyback yield (%): 0.07695556616251169
Retained earnings: 25197916.666666668
Inventory turnover: 3.2197588047561214
Receivables turnover: 6.389097768647364
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.526727534175
FCF margin (%): 5.018028420799317
Revenue growth (%): -13.032780773040386
Rule of 40 score: -8.014752352241068
Financial ratios for AKW.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.032608695652173
Shares outstanding: 26544196
Market cap (USD): 186674943.60869563
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AKW.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.776470588235295
Shares outstanding: 26544196
Market cap (USD): 286052747.482353
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALNMR.PA — annual report dated 2021-12-31
Total revenue: 1775235.2272727273
Gross profit: 946465.9090909091
Operating income: -4540665.909090909
Net income: -3806928.409090909
Capital expenditures: 0
Depreciation & amortization: 2128717.0454545454
Net tangible assets: 135722.72727272726
Owner earnings: -1678211.3636363638
Return on net tangible assets (%): -1236.4998827824109
Buffett classification: The Gruesome
Stock price: 8.534090909090908
Shares outstanding: 5815301
Book value: 5308278.40909091
P/B ratio: 9.349228426439403
Market cap (USD): 49628307.397727266
Debt to equity: 0.8803509098674133
Current ratio: 2.0619060250953436
Quick ratio: 2.0619060250953436
Interest coverage ratio: -101.81124671949448
COGS to revenue (%): 46.68504237914694
Buyback yield (%): 0
Retained earnings: -3806928.409090909
Receivables turnover: 2.0668597420604473
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -45.49115373953098
Rule of 40 score: 0
Financial ratios for ALNMR.PA — annual report dated 2022-12-31
Total revenue: 999076.595744681
Gross profit: -55488.29787234043
Operating income: -5769388.29787234
Net income: -5257091.489361702
Capital expenditures: 0
Depreciation & amortization: 2533025.5319148935
Net tangible assets: -5010697.872340426
Owner earnings: -2724065.957446809
Buffett classification: The Gruesome
Stock price: 2.8723404255319154
Shares outstanding: 5815301
Book value: -287639.3617021274
Market cap (USD): 16703524.148936173
Debt to equity: -21.367788417085542
Current ratio: 1.3275674768107129
Quick ratio: 1.3275674768107129
Interest coverage ratio: -139.22840932429656
COGS to revenue (%): 105.55395833599536
Buyback yield (%): 0
Retained earnings: -5257091.489361702
Receivables turnover: 6.538504918854565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -98.47759196595646
Revenue growth (%): -43.721452774483836
Rule of 40 score: -43.721452774483836
Financial ratios for ALNMR.PA — annual report dated 2023-12-31
Total revenue: 2117182.222222222
Gross profit: 913641.1111111111
Operating income: -4786088.888888889
Net income: -4482560
Capital expenditures: 0
Depreciation & amortization: 2586248.888888889
Net tangible assets: -4891341.111111111
Owner earnings: -1896311.111111111
Buffett classification: The Gruesome
Stock price: 0.8777777777777778
Shares outstanding: 5815301
Book value: 126531.11111111008
P/B ratio: 40.3421889214777
Market cap (USD): 5104541.988888889
Debt to equity: 57.39845273011515
Current ratio: 1.9365437962041934
Quick ratio: 1.9365437962041934
Interest coverage ratio: -66.76193428394296
COGS to revenue (%): 56.84636393025531
Buyback yield (%): 0
Retained earnings: -4482561.111111111
Receivables turnover: 2.0662267741638156
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.54374812792294
Revenue growth (%): 111.91390442332796
Rule of 40 score: 111.91390442332796
Financial ratios for ALR.AX — annual report dated 2021-06-30
Operating income: -1071865.4135338345
Net income: -1047957.894736842
Capital expenditures: 1242715.789473684
Net tangible assets: 8399928.57142857
Owner earnings: -2290673.684210526
Return on net tangible assets (%): -27.270156701117664
Buffett classification: The Gruesome
Stock price: 0.015037593984962405
Shares outstanding: 6628932966
Book value: 8399928.57142857
P/B ratio: 11.867148827348604
Market cap (USD): 99683202.4962406
Debt to equity: 0
Current ratio: 97.49773307932007
Quick ratio: 97.49773307932007
Free cash flow (dilution-adjusted): -1916236.0902255639
Buyback yield (%): 0.038844109801788575
Retained earnings: -6500201.503759398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.760411048966134
Rule of 40 score: 0
Financial ratios for ALR.AX — annual report dated 2022-06-30
Operating income: -1958812.4137931035
Net income: -1950308.275862069
Capital expenditures: 2934514.4827586208
Net tangible assets: 7677375.172413793
Owner earnings: -4884822.75862069
Return on net tangible assets (%): -63.626208813824114
Buffett classification: The Gruesome
Stock price: 0.006896551724137932
Shares outstanding: 6628932966
Book value: 7677375.172413793
P/B ratio: 5.9547407869464015
Market cap (USD): 45716779.07586207
Debt to equity: 0
Current ratio: 3.83631776312478
Quick ratio: 3.83631776312478
Free cash flow (dilution-adjusted): -3723367.5862068967
Buyback yield (%): 0
Retained earnings: -7912562.068965518
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.514090034722713
Rule of 40 score: 0
Financial ratios for ALR.AX — annual report dated 2023-06-30
Operating income: -2419226.490066225
Net income: -2415449.668874172
Capital expenditures: 1395637.7483443709
Net tangible assets: 6740139.072847682
Owner earnings: -3811087.4172185427
Return on net tangible assets (%): -56.543156988723275
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 6628932966
Book value: 6740139.072847682
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 1.7434410034597216
Quick ratio: 1.7434410034597216
Free cash flow (dilution-adjusted): -2625125.1655629138
Retained earnings: -10013542.38410596
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.892827490933534
Rule of 40 score: 0
Financial ratios for ALR.AX — annual report dated 2024-06-30
Operating income: -2182243.3333333335
Net income: -2175046
Capital expenditures: 369430
Net tangible assets: 6754027.333333333
Owner earnings: -2544476
Return on net tangible assets (%): -37.673463171257524
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 6628932966
Book value: 6754027.333333333
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.9875928645043714
Quick ratio: 3.9875928645043714
Free cash flow (dilution-adjusted): -1288483.3333333333
Retained earnings: -11497368.666666666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.310253210899056
Rule of 40 score: 0
Financial ratios for AUA.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07518796992481203
Shares outstanding: 180976547
Market cap (USD): 13607259.17293233
Buyback yield (%): 2.61964330659928
Capitalized R&D asset: 44526.31578947368
Rule of 40 score: 0
Financial ratios for AUA.AX — annual report dated 2022-06-30
Total revenue: 1425800.6896551724
Gross profit: 652491.0344827586
Operating income: -2195018.620689655
Net income: -2037280.6896551724
Capital expenditures: 138814.4827586207
Depreciation & amortization: 84856.55172413793
Net tangible assets: 2752829.6551724137
Owner earnings: -2091238.6206896552
Return on net tangible assets (%): -75.96687345910904
Buffett classification: The Gruesome
Stock price: 0.06206896551724138
Shares outstanding: 180976547
Book value: 2849355.172413793
P/B ratio: 3.9423049691823806
Market cap (USD): 11233027.055172414
Debt to equity: 0.06658639038717776
Current ratio: 4.141015512231965
Quick ratio: 3.522449190829645
Interest coverage ratio: -203.19056435137895
COGS to revenue (%): 54.23686920501052
R&D to revenue (%): 8.015193882590351
SG&A to revenue (%): 133.40845143998942
Free cash flow (dilution-adjusted): -2606737.931034483
Buyback yield (%): 0.22420339114744828
Retained earnings: -5018378.620689656
Inventory turnover: 1.4658614640064214
Receivables turnover: 2.63144891841839
Capitalized R&D asset: 144113.3212341198
ROCI (R&D-adjusted, %): -68.54024578960873
FCF margin (%): -182.82624983614775
Rule of 40 score: -182.82624983614775
Financial ratios for AUA.AX — annual report dated 2023-06-30
Total revenue: 1822609.2715231788
Gross profit: 655471.5231788079
Operating income: -2748052.9801324503
Net income: -2478759.6026490065
Capital expenditures: 10599.337748344371
Depreciation & amortization: 92956.29139072848
Net tangible assets: 2070040.3973509935
Owner earnings: -2396402.6490066224
Return on net tangible assets (%): -115.76598466741376
Buffett classification: The Gruesome
Stock price: 0.019867549668874173
Shares outstanding: 180976547
Book value: 2099086.754966887
P/B ratio: 1.7129165947600677
Market cap (USD): 3595560.536423841
Debt to equity: 0.06648712890279311
Current ratio: 3.0428684244805804
Quick ratio: 2.4886800927031545
Interest coverage ratio: -351.3598645215919
COGS to revenue (%): 64.03664057787758
SG&A to revenue (%): 159.0333703954014
Free cash flow (dilution-adjusted): -1975998.013245033
Buyback yield (%): 0
Retained earnings: -7297732.450331125
Inventory turnover: 2.1575374580551805
Receivables turnover: 3.2481101846442546
Capitalized R&D asset: 91261.74627949185
ROCI (R&D-adjusted, %): -124.45156221938024
Rosenberg metric: 0.026080422729706707
FCF margin (%): -108.41588727317651
Revenue growth (%): 27.830578617827285
Rule of 40 score: -80.58530865534922
Financial ratios for AUA.AX — annual report dated 2024-06-30
Total revenue: 2123404.6666666665
Gross profit: 628748
Operating income: -1911007.3333333333
Net income: -1068382.6666666667
Capital expenditures: 5644
Depreciation & amortization: 75156
Net tangible assets: 1045124.6666666666
Owner earnings: -998870.6666666667
Return on net tangible assets (%): -95.57430788161159
Buffett classification: The Gruesome
Stock price: 0.02666666666666667
Shares outstanding: 180976547
Book value: 931174
P/B ratio: 5.182749146060063
Market cap (USD): 4826041.253333334
Debt to equity: 0.08031581637803462
Current ratio: 1.4235604802349358
Quick ratio: 1.0354620453799142
COGS to revenue (%): 70.389628982637
SG&A to revenue (%): 81.90613376567883
Free cash flow (dilution-adjusted): -893524
Buyback yield (%): 0
Retained earnings: -8414766.666666666
Inventory turnover: 1.7712308161462753
Receivables turnover: 1.6383831733155696
Capitalized R&D asset: 37712.6275862069
ROCI (R&D-adjusted, %): -198.6982126110826
FCF margin (%): -42.07977942342283
Revenue growth (%): 16.503558927477037
Rule of 40 score: -25.57622049594579
Financial ratios for BRY.AX — annual report dated 2021-06-30
Operating income: -891948.1203007519
Net income: -934642.857142857
Capital expenditures: 0
Depreciation & amortization: 89.47368421052632
Net tangible assets: 438023.30827067664
Owner earnings: -934553.3834586465
Return on net tangible assets (%): -213.35699854609996
Buffett classification: The Gruesome
Stock price: 0.18796992481203006
Shares outstanding: 264033878
Book value: 438023.30827067664
P/B ratio: 113.30545032279328
Market cap (USD): 49630428.19548872
Debt to equity: 0
Current ratio: 6.045341163020319
Quick ratio: 6.045341163020319
Free cash flow (dilution-adjusted): -837963.1578947369
Buyback yield (%): 0
Retained earnings: -6516163.909774436
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -203.63028712380125
Rule of 40 score: 0
Financial ratios for BRY.AX — annual report dated 2022-06-30
Operating income: -5043482.75862069
Net income: -3132678.620689655
Capital expenditures: 0
Depreciation & amortization: 31.724137931034484
Net tangible assets: 3256695.8620689656
Owner earnings: -3132646.896551724
Return on net tangible assets (%): -96.19095639350142
Buffett classification: The Gruesome
Stock price: 0.20689655172413793
Shares outstanding: 264033878
Book value: 3256695.8620689656
P/B ratio: 16.7739639223931
Market cap (USD): 54627698.89655172
Debt to equity: 0
Current ratio: 11.244770756104884
Quick ratio: 11.244770756104884
Free cash flow (dilution-adjusted): -1600475.1724137932
Buyback yield (%): 0.26432087880278254
Retained earnings: -9109573.793103449
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -154.86502185735532
Rule of 40 score: 0
Financial ratios for BRY.AX — annual report dated 2023-06-30
Operating income: -3485909.2715231786
Net income: -3493492.715231788
Capital expenditures: 0
Net tangible assets: 1036315.2317880795
Owner earnings: -3493492.715231788
Return on net tangible assets (%): -337.10714733045506
Buffett classification: The Gruesome
Stock price: 0.06622516556291391
Shares outstanding: 264033878
Book value: 1036315.2317880795
P/B ratio: 16.872942468092504
Market cap (USD): 17485687.284768213
Debt to equity: 0
Current ratio: 4.489733709657626
Quick ratio: 4.489733709657626
Free cash flow (dilution-adjusted): -2236367.549668874
Buyback yield (%): 0.035646940730840605
Retained earnings: -12241096.688741721
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -336.37537735583794
Rule of 40 score: 0
Financial ratios for BRZE — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.02
Shares outstanding: 112631669
Market cap (USD): 5633836083.38
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRZE — annual report dated 2023-01-31
Total revenue: 355426000
Gross profit: 239608000
Operating income: -148140000
Net income: -138966000
Capital expenditures: 15447000
Operating cash flow: -22308000
Depreciation & amortization: 4618000
Net tangible assets: 444803000
Owner earnings: -149795000
Return on net tangible assets (%): -33.67670631717862
Buffett classification: The Gruesome
Stock price: 32
Shares outstanding: 112631669
Book value: 446758000
P/B ratio: 8.067484875480686
Market cap (USD): 3604213408
Debt to equity: 0.11479369143921317
Current ratio: 2.6836767094793905
Quick ratio: 2.6836767094793905
COGS to revenue (%): 32.5856859093032
R&D to revenue (%): 27.373630516619496
SG&A to revenue (%): 81.72024556447755
Free cash flow (dilution-adjusted): -111256000
Buyback yield (%): 0
Retained earnings: -353927000
Receivables turnover: 4.366627352695464
Capitalized R&D asset: 97293000
ROCI (R&D-adjusted, %): -14.225925698159877
FCF margin (%): -31.302155722991564
Rule of 40 score: -31.302155722991564
Financial ratios for BRZE — annual report dated 2024-01-31
Total revenue: 471800000
Gross profit: 324273000
Operating income: -144692000
Net income: -129166000
Capital expenditures: 9761000
Operating cash flow: 6850000
Depreciation & amortization: 6963000
Net tangible assets: 412095000
Owner earnings: -131964000
Return on net tangible assets (%): -32.0227132093328
Buffett classification: The Gruesome
Stock price: 54.05
Shares outstanding: 112631669
Book value: 444425000
P/B ratio: 13.698018134555886
Market cap (USD): 6087741709.45
Debt to equity: 0.20388592000900038
Current ratio: 2.07684866241246
Quick ratio: 2.07684866241246
COGS to revenue (%): 31.26896990250106
R&D to revenue (%): 25.405468418821535
SG&A to revenue (%): 73.99364137346333
Free cash flow (dilution-adjusted): -103717000
Buyback yield (%): 0
Retained earnings: -483093000
Receivables turnover: 4.849518954033385
Capitalized R&D asset: 185049310
ROCI (R&D-adjusted, %): -13.758991308548183
Rosenberg metric: 0.8702064896755162
FCF margin (%): -21.983255616786774
Revenue growth (%): 32.74211790921317
Rule of 40 score: 10.758862292426397
Financial ratios for BRZE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.46
Shares outstanding: 112631669
Market cap (USD): 3543392306.7400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRZE — annual report dated 2025-01-31
Total revenue: 593410000
Gross profit: 410219000
Operating income: -122159000
Net income: -103743000
Capital expenditures: 13234000
Operating cash flow: 36680000
Depreciation & amortization: 10115000
Net tangible assets: 443283000
Owner earnings: -106862000
Return on net tangible assets (%): -24.106947480503425
Buffett classification: The Gruesome
Stock price: 45.98
Shares outstanding: 112631669
Book value: 474749000
P/B ratio: 10.908509845455177
Market cap (USD): 5178804140.62
Debt to equity: 0.18418153592740585
Current ratio: 1.9848124828570284
Quick ratio: 1.9848124828570284
COGS to revenue (%): 30.870898704100032
R&D to revenue (%): 22.576127803710758
SG&A to revenue (%): 67.13890901737416
Free cash flow (dilution-adjusted): -95508000
Buyback yield (%): 0
Retained earnings: -586836000
Receivables turnover: 5.8199133010337185
Capitalized R&D asset: 246383900
ROCI (R&D-adjusted, %): -13.27166305400139
Rosenberg metric: 0.7170352819468894
FCF margin (%): -16.0947742707403
Revenue growth (%): 25.775752437473503
Rule of 40 score: 9.680978166733205
Financial ratios for BRZE — quarterly report dated 2025-01-31
Total revenue: 160400000
Gross profit: 111087000
Operating income: -21559000
Net income: -17064000
Capital expenditures: 1087000
Operating cash flow: 17083000
Depreciation & amortization: 2747000
Net tangible assets: 443283000
Owner earnings: -15404000
Return on net tangible assets (%): -3.4749809940827867
Buffett classification: The Gruesome
Stock price: 45.98
Shares outstanding: 112631669
Book value: 474749000
P/B ratio: 10.908509845455177
Market cap (USD): 5178804140.62
Debt to equity: 0.18418153592740585
Current ratio: 1.9848124828570284
Quick ratio: 1.9848124828570284
COGS to revenue (%): 30.74376558603491
R&D to revenue (%): 20.947630922693268
SG&A to revenue (%): 61.74937655860349
Free cash flow (dilution-adjusted): -12751000
Buyback yield (%): 0
Retained earnings: -586836000
Receivables turnover: 1.573135089543163
Capitalized R&D asset: 33600000
ROCI (R&D-adjusted, %): 0.14496975630945957
FCF margin (%): -7.949501246882792
Rule of 40 score: -7.949501246882792
Financial ratios for BRZE — quarterly report dated 2025-04-30
Total revenue: 162059000
Gross profit: 111202000
Operating income: -40222000
Net income: -35641000
Capital expenditures: 217000
Operating cash flow: 24144000
Depreciation & amortization: 2606000
Net tangible assets: 442949000
Owner earnings: -33252000
Return on net tangible assets (%): -7.5069590404312905
Buffett classification: The Gruesome
Stock price: 31.13
Shares outstanding: 112631669
Book value: 474459000
P/B ratio: 7.389940660773639
Market cap (USD): 3506223855.97
Debt to equity: 0.1840222232057986
Current ratio: 1.9168651468753544
Quick ratio: 1.9168651468753544
COGS to revenue (%): 31.381780709494688
R&D to revenue (%): 22.705928087918597
SG&A to revenue (%): 70.73164711617373
Free cash flow (dilution-adjusted): -7771000
Buyback yield (%): 0
Retained earnings: -622622000
Receivables turnover: 1.7799097189425475
Capitalized R&D asset: 59309000
ROCI (R&D-adjusted, %): -4.44782603901331
Rosenberg metric: 0.0034226190476190476
FCF margin (%): -4.795167192195435
Revenue growth (%): 1.03428927680798
Rule of 40 score: -3.7608779153874545
Financial ratios for BRZE — quarterly report dated 2025-07-31
Total revenue: 180111000
Gross profit: 121890000
Operating income: -38753000
Net income: -27763000
Capital expenditures: 2609000
Operating cash flow: 6952000
Depreciation & amortization: 4766000
Net tangible assets: 263460000
Owner earnings: -25606000
Return on net tangible assets (%): -9.719122447430351
Buffett classification: The Gruesome
Stock price: 27.87
Shares outstanding: 112631669
Book value: 599050000
P/B ratio: 5.240037751489859
Market cap (USD): 3139044615.03
Debt to equity: 0.14092813621567482
Current ratio: 1.369970112621974
Quick ratio: 1.369970112621974
COGS to revenue (%): 32.32506620917101
R&D to revenue (%): 22.902543431550544
SG&A to revenue (%): 66.2885664951058
Free cash flow (dilution-adjusted): -34022000
Buyback yield (%): 0
Retained earnings: -650521000
Receivables turnover: 1.9273515248796147
Capitalized R&D asset: 76991990
ROCI (R&D-adjusted, %): -4.654800464981299
Rosenberg metric: 0.29045846128760494
FCF margin (%): -18.889462609168792
Revenue growth (%): 11.139153024515764
Rule of 40 score: -7.750309584653028
Financial ratios for BRZE — quarterly report dated 2025-10-31
Total revenue: 190842000
Gross profit: 128211000
Operating income: -37545000
Net income: -35800000
Capital expenditures: 1942000
Operating cash flow: 20967000
Depreciation & amortization: 5987000
Net tangible assets: 270524000
Owner earnings: -31755000
Return on net tangible assets (%): -11.738330055743667
Buffett classification: The Gruesome
Stock price: 28.66
Shares outstanding: 112631669
Book value: 602399000
P/B ratio: 5.3586138647972525
Market cap (USD): 3228023633.54
Debt to equity: 0.13935282097081836
Current ratio: 1.3591901821223877
Quick ratio: 1.3591901821223877
COGS to revenue (%): 32.81824755556953
R&D to revenue (%): 23.09082906278492
SG&A to revenue (%): 63.76426572767001
Free cash flow (dilution-adjusted): -20049000
Buyback yield (%): 0
Retained earnings: -686519000
Receivables turnover: 1.9894295721791344
Capitalized R&D asset: 83847510
ROCI (R&D-adjusted, %): -4.522919637688503
Rosenberg metric: 0.15323636363636364
FCF margin (%): -10.505549092966957
Revenue growth (%): 5.957992571247731
Rule of 40 score: -4.547556521719226
Financial ratios for BRZE — quarterly report dated 2026-01-31
Total revenue: 205170000
Gross profit: 134354000
Operating income: -28237000
Net income: -31582000
Capital expenditures: 4820000
Operating cash flow: 19375000
Depreciation & amortization: 5969000
Net tangible assets: 300423000
Owner earnings: -30433000
Return on net tangible assets (%): -10.130049962885664
Buffett classification: The Gruesome
Stock price: 20.82
Shares outstanding: 112631669
Book value: 624156000
P/B ratio: 3.7570596911349083
Market cap (USD): 2344991348.58
Debt to equity: 0.1324252270265767
Current ratio: 1.35087318690624
Quick ratio: 1.35087318690624
COGS to revenue (%): 34.51576741238973
R&D to revenue (%): 21.947165764975388
SG&A to revenue (%): 57.29980016571623
Free cash flow (dilution-adjusted): -23822000
Buyback yield (%): 0
Retained earnings: -718123000
Receivables turnover: 1.55376494732936
Capitalized R&D asset: 88166390
ROCI (R&D-adjusted, %): -3.4109208421240678
Rosenberg metric: 0.139401366101618
FCF margin (%): -11.610859287420189
Revenue growth (%): 7.5077813060018235
Rule of 40 score: -4.103077981418365
Financial ratios for BRZE — annual report dated 2026-01-31
Total revenue: 738182000
Gross profit: 495657000
Operating income: -144757000
Net income: -130786000
Capital expenditures: 9588000
Operating cash flow: 71438000
Depreciation & amortization: 19328000
Net tangible assets: 300423000
Owner earnings: -121046000
Return on net tangible assets (%): -40.29185515090389
Buffett classification: The Gruesome
Stock price: 20.82
Shares outstanding: 112631669
Book value: 624156000
P/B ratio: 3.7570596911349083
Market cap (USD): 2344991348.58
Debt to equity: 0.1324252270265767
Current ratio: 1.35087318690624
Quick ratio: 1.35087318690624
COGS to revenue (%): 32.85436382897443
R&D to revenue (%): 22.642519053566733
SG&A to revenue (%): 64.11305071107125
Free cash flow (dilution-adjusted): -85664000
Buyback yield (%): 0
Retained earnings: -718123000
Receivables turnover: 5.590297394109673
Capitalized R&D asset: 296457020
ROCI (R&D-adjusted, %): -11.915437221349015
Rosenberg metric: 0.6377445528443147
FCF margin (%): -11.604726205732462
Revenue growth (%): 24.396622908275898
Rule of 40 score: 12.791896702543436
Financial ratios for BXMT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.88
Shares outstanding: 168683520
Market cap (USD): 3184744857.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BXMT — annual report dated 2022-12-31
Total revenue: 628050000
Net income: 251057000
Capital expenditures: 0
Operating cash flow: 396825000
Depreciation & amortization: 0
Net tangible assets: 4518794000
Owner earnings: 251057000
Return on net tangible assets (%): 5.555840784067607
Buffett classification: The Gruesome
Stock price: 14.35
P/E ratio: 9.641669071167106
Shares outstanding: 168683520
Book value: 4544200000
P/B ratio: 0.5326808925663483
Market cap (USD): 2420608512
Debt to equity: 4.498804189956428
Effective tax rate (%): 1.1820042509643391
COGS to revenue (%): 0
SG&A to revenue (%): 6.570973648594858
Free cash flow (dilution-adjusted): 363411000
Buyback yield (%): 0
Retained earnings: -968749000
Receivables turnover: 3.313041689305741
Capitalized R&D asset: 0
FCF margin (%): 57.86338667303559
Rule of 40 score: 57.86338667303559
Financial ratios for BXMT — annual report dated 2023-12-31
Total revenue: 670665000
Net income: 249897000
Capital expenditures: 0
Operating cash flow: 458841000
Depreciation & amortization: 0
Net tangible assets: 4367711000
Owner earnings: 249897000
Return on net tangible assets (%): 5.721463714059836
Buffett classification: The Gruesome
Stock price: 16.28
P/E ratio: 10.989198372129318
Shares outstanding: 168683520
Book value: 4387504000
P/B ratio: 0.6259065987404229
Market cap (USD): 2746167705.6000004
Debt to equity: 4.398780946980334
Effective tax rate (%): 2.1006115357342936
COGS to revenue (%): 0
SG&A to revenue (%): 5.647230733674786
Free cash flow (dilution-adjusted): 428186000
Buyback yield (%): 0
Retained earnings: -1150934000
Receivables turnover: 3.1217678683640933
Capitalized R&D asset: 0
FCF margin (%): 63.84498967442762
Revenue growth (%): 6.785287795557679
Rule of 40 score: 70.6302774699853
Financial ratios for BXMT — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1029000
Buffett classification: The Gruesome
Stock price: 15.93
Shares outstanding: 168683520
Market cap (USD): 2687128473.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BXMT — annual report dated 2024-12-31
Total revenue: 493175000
Net income: -201833000
Capital expenditures: 590000
Operating cash flow: 366453000
Depreciation & amortization: 9407000
Net tangible assets: 3710019000
Owner earnings: -193016000
Return on net tangible assets (%): -5.20256095723499
Buffett classification: The Gruesome
Stock price: 14.99
Shares outstanding: 168683520
Book value: 3794189000
P/B ratio: 0.6664312096208175
Market cap (USD): 2528565964.8
Debt to equity: 4.145460597772014
COGS to revenue (%): 0
SG&A to revenue (%): 7.856440411618594
Free cash flow (dilution-adjusted): 334625000
Buyback yield (%): 1.1561098427705927
Retained earnings: -1733741000
Receivables turnover: 3.079822145618275
Capitalized R&D asset: 0
FCF margin (%): 67.8511684493334
Revenue growth (%): -26.464777496961972
Rule of 40 score: 41.38639095237143
Financial ratios for BXMT — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 8193000
Buffett classification: The Gruesome
Stock price: 14.99
Shares outstanding: 168683520
Market cap (USD): 2528565964.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BXMT — quarterly report dated 2025-03-31
Total revenue: 126947000
Net income: -351000
Capital expenditures: 0
Operating cash flow: 100516000
Net tangible assets: 3600587000
Owner earnings: -351000
Return on net tangible assets (%): -0.009748410467515435
Buffett classification: The Gruesome
Stock price: 17.64
Shares outstanding: 168683520
Book value: 3688718000
P/B ratio: 0.8066697678705719
Market cap (USD): 2975577292.8
Debt to equity: 4.318245254855481
Effective tax rate (%): 195.64032697547685
COGS to revenue (%): 0
SG&A to revenue (%): 6.89500342662686
Free cash flow (dilution-adjusted): 93551000
Buyback yield (%): 1.0635583245165972
Retained earnings: -1814935000
Receivables turnover: 0.8660181325765587
Capitalized R&D asset: 0
FCF margin (%): 73.69295847873522
Rule of 40 score: 73.69295847873522
Financial ratios for BXMT — quarterly report dated 2025-06-30
Total revenue: 133853000
Net income: 6984000
Capital expenditures: 0
Operating cash flow: 57233000
Depreciation & amortization: 16707000
Net tangible assets: 3545648000
Owner earnings: 23691000
Return on net tangible assets (%): 0.6681712341439421
Buffett classification: The Gruesome
Stock price: 17.39
P/E ratio: 442.24429561284484
Shares outstanding: 168683520
Book value: 3623537000
P/B ratio: 0.8095422822507401
Market cap (USD): 2933406412.8
Debt to equity: 4.575128665720814
Effective tax rate (%): 11.449220235831115
COGS to revenue (%): 0
SG&A to revenue (%): 6.906830627628817
Free cash flow (dilution-adjusted): 49930000
Buyback yield (%): 0.0013295123318004085
Retained earnings: -1888762000
Receivables turnover: 0.788070580339007
Capitalized R&D asset: 0
FCF margin (%): 37.30211500676115
Revenue growth (%): 5.4400655391620125
Rule of 40 score: 42.74218054592316
Financial ratios for BXMT — quarterly report dated 2025-09-30
Total revenue: 132711000
Net income: 63408000
Capital expenditures: 0
Operating cash flow: -18184000
Net tangible assets: 3494030000
Owner earnings: 63408000
Return on net tangible assets (%): 1.81475259227883
Buffett classification: The Gruesome
Stock price: 17.06
P/E ratio: 41.08651862766094
Shares outstanding: 168683520
Book value: 3597403000
P/B ratio: 0.7999495333717128
Market cap (USD): 2877740851.2
Debt to equity: 4.391565526575699
Effective tax rate (%): 2.32902033271719
COGS to revenue (%): 0
SG&A to revenue (%): 7.080046115242896
Free cash flow (dilution-adjusted): -25486000
Buyback yield (%): 0.558285155986182
Retained earnings: -1905746000
Receivables turnover: 0.960768840946934
Capitalized R&D asset: 0
FCF margin (%): -19.204135301519845
Revenue growth (%): -0.8531747514063936
Rule of 40 score: -20.057310052926237
Financial ratios for BXMT — quarterly report dated 2025-12-31
Total revenue: 159323000
Net income: 39628000
Capital expenditures: 0
Operating cash flow: 136308000
Net tangible assets: 3381821000
Owner earnings: 39628000
Return on net tangible assets (%): 1.1717947224291292
Buffett classification: The Gruesome
Stock price: 18.16
P/E ratio: 27.93216609251475
Shares outstanding: 168683520
Book value: 3504390000
P/B ratio: 0.8741300834667375
Market cap (USD): 3063292723.2
Debt to equity: 4.612386463835361
Effective tax rate (%): 1.3320718073849065
COGS to revenue (%): 0
SG&A to revenue (%): 5.511445302938057
Free cash flow (dilution-adjusted): 129616000
Buyback yield (%): 2.015967965852412
Retained earnings: -1945428000
Receivables turnover: 1.1981425079902237
Capitalized R&D asset: 0
FCF margin (%): 81.3542300860516
Revenue growth (%): 20.052595489446993
Rule of 40 score: 101.4068255754986
Financial ratios for BXMT — annual report dated 2025-12-31
Total revenue: 552834000
Net income: 109669000
Capital expenditures: 0
Operating cash flow: 275873000
Net tangible assets: 3381821000
Owner earnings: 109669000
Return on net tangible assets (%): 3.2428978352195457
Buffett classification: The Gruesome
Stock price: 18.16
P/E ratio: 27.93216609251475
Shares outstanding: 168683520
Book value: 3504390000
P/B ratio: 0.8741300834667375
Market cap (USD): 3063292723.2
Debt to equity: 4.612386463835361
Effective tax rate (%): 3.2363658822802797
COGS to revenue (%): 0
SG&A to revenue (%): 6.543555570026445
Free cash flow (dilution-adjusted): 247611000
Buyback yield (%): 3.5748134407999372
Retained earnings: -1945428000
Receivables turnover: 4.157428087986464
Capitalized R&D asset: 0
FCF margin (%): 44.78939428472199
Revenue growth (%): 12.096922998935469
Rule of 40 score: 56.88631728365746
Financial ratios for BZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.25
Shares outstanding: 385186790
Market cap (USD): 13192647557.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BZ — annual report dated 2022-12-31
Total revenue: 648141091.954023
Gross profit: 539684051.7241379
Operating income: -18609051.724137932
Net income: 15408764.367816092
Capital expenditures: 48821264.36781609
Operating cash flow: 144115229.88505748
Depreciation & amortization: 41293103.448275864
Net tangible assets: 1670233045.9770114
Owner earnings: 7880603.448275864
Return on net tangible assets (%): 0.47182657936611866
Buffett classification: The Gruesome
Stock price: 20
P/E ratio: 499.9580508928155
Shares outstanding: 385186790
Book value: 1672523419.5402298
P/B ratio: 4.60605556250909
Market cap (USD): 7703735800
Debt to equity: 0.025344472694788133
Current ratio: 4.5614532502790235
Quick ratio: 4.5614532502790235
Effective tax rate (%): 8.33447297343499
COGS to revenue (%): 16.73355409435738
R&D to revenue (%): 26.218127793410957
SG&A to revenue (%): 60.30950139900537
Free cash flow (dilution-adjusted): -4207183.908045977
Buyback yield (%): 1.7137789174961064
Retained earnings: -515298850.57471263
Receivables turnover: 18.0818582651916
Capitalized R&D asset: 169930459.77011496
ROCI (R&D-adjusted, %): 5.0773175130861565
FCF margin (%): -0.6491154411089894
Rule of 40 score: -0.6491154411089894
Financial ratios for BZ — annual report dated 2023-12-31
Total revenue: 837134739.8030941
Gross profit: 688068495.0773559
Operating income: 81711814.34599155
Net income: 154602953.58649787
Capital expenditures: 133411814.34599155
Operating cash flow: 428552601.9690576
Depreciation & amortization: 60181293.95218003
Net tangible assets: 1886838115.3305204
Owner earnings: 81372433.19268635
Return on net tangible assets (%): 4.31263458860286
Capex to operating income (%): 163.27114434283297
Buffett classification: The Gruesome
Stock price: 16.49
P/E ratio: 41.08414502926238
Shares outstanding: 385186790
Book value: 1888775386.779184
P/B ratio: 3.3628827501459693
Market cap (USD): 6351730167.099999
Debt to equity: 0.02085702394775323
Current ratio: 3.0690749953354683
Quick ratio: 3.0690749953354683
Effective tax rate (%): 10.03209228434697
COGS to revenue (%): 17.80672066730869
R&D to revenue (%): 25.93348015163907
SG&A to revenue (%): 47.093410850889825
Free cash flow (dilution-adjusted): 145503656.82137832
Buyback yield (%): 0.15906493603520067
Retained earnings: -350527848.1012658
Receivables turnover: 25.474664555201265
Capitalized R&D asset: 330951579.6352879
ROCI (R&D-adjusted, %): 7.5759231863684215
Rosenberg metric: 0.8732068609356742
FCF margin (%): 17.381151432755356
Revenue growth (%): 29.159337402800826
Rule of 40 score: 46.54048883555618
Financial ratios for BZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.24
Shares outstanding: 385186790
Market cap (USD): 6640620259.599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BZ — annual report dated 2024-12-31
Total revenue: 1007626986.3013699
Gross profit: 837803424.6575342
Operating income: 160677534.24657536
Net income: 217077260.2739726
Capital expenditures: 117250273.97260274
Operating cash flow: 485273287.6712329
Depreciation & amortization: 94038767.12328768
Net tangible assets: 2001130684.9315069
Owner earnings: 193865753.42465758
Return on net tangible assets (%): 9.687810740421137
Capex to operating income (%): 72.97241305226328
Buffett classification: The Good
Stock price: 13.7
P/E ratio: 24.309589204967107
Shares outstanding: 385186790
Book value: 2049701369.8630137
P/B ratio: 2.574550176230149
Market cap (USD): 5277059023
Debt to equity: 0.02019184886271438
Current ratio: 3.602142480921056
Quick ratio: 3.6014168226760326
Effective tax rate (%): 14.4944506891622
COGS to revenue (%): 16.853812368324494
R&D to revenue (%): 24.685817498511696
SG&A to revenue (%): 43.05519396786998
Free cash flow (dilution-adjusted): 211337397.26027396
Buyback yield (%): 4.288033425593174
Retained earnings: -125704109.5890411
Inventory turnover: 407.53188691650234
Receivables turnover: 43.85244161991689
Capitalized R&D asset: 450273785.5930858
ROCI (R&D-adjusted, %): 7.833021022638712
Rosenberg metric: 0.6897106893347544
FCF margin (%): 20.97377304631511
Revenue growth (%): 20.36616549187505
Rule of 40 score: 41.33993853819016
Financial ratios for BZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.7
Shares outstanding: 385186790
Market cap (USD): 5277059023
Buyback yield (%): 0
Retained earnings: -125704109.5890411
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BZ — quarterly report dated 2025-03-31
Total revenue: 264914187.3278237
Gross profit: 222103168.04407713
Operating income: 60576446.28099174
Net income: 71368319.55922866
Capital expenditures: 0
Operating cash flow: 138169283.7465565
Net tangible assets: 2137434159.7796144
Owner earnings: 71368319.55922866
Return on net tangible assets (%): 3.338971599788939
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.04
P/E ratio: 25.69051831013598
Shares outstanding: 385186790
Book value: 2184185950.4132233
P/B ratio: 3.3577527958242284
Market cap (USD): 7333956481.599999
Debt to equity: 0.015204963805062562
Current ratio: 3.558574401100546
Quick ratio: 3.557924912079566
Effective tax rate (%): 12.922215722816993
COGS to revenue (%): 16.160334678780018
R&D to revenue (%): 22.023244701621245
SG&A to revenue (%): 39.346282412777775
Free cash flow (dilution-adjusted): 138169283.7465565
Buyback yield (%): 0
Retained earnings: -55028374.65564738
Inventory turnover: 108.59818308874912
Receivables turnover: 2.8615637093498507
Capitalized R&D asset: 58342699.72451791
ROCI (R&D-adjusted, %): 4.4021227971616925
FCF margin (%): 52.15624166461722
Rule of 40 score: 52.15624166461722
Financial ratios for BZ — quarterly report dated 2025-06-30
Total revenue: 293226359.832636
Gross profit: 250345327.75453278
Operating income: 90823012.55230126
Net income: 100758437.9358438
Capital expenditures: 0
Operating cash flow: 146707949.79079497
Net tangible assets: 2302180474.1980476
Owner earnings: 100758437.9358438
Return on net tangible assets (%): 4.376652441678903
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.72
P/E ratio: 39.65397372337881
Shares outstanding: 385186790
Book value: 2348251464.4351463
P/B ratio: 2.9066350099953295
Market cap (USD): 6825509918.799999
Debt to equity: 0.011848098733720565
Current ratio: 3.923749431302257
Quick ratio: 3.9231108852051753
Effective tax rate (%): 12.010095948629438
COGS to revenue (%): 14.623866729641325
R&D to revenue (%): 19.78878756183907
SG&A to revenue (%): 34.761963877089066
Free cash flow (dilution-adjusted): 146707949.79079497
Buyback yield (%): 0
Inventory turnover: 113.62047302291205
Receivables turnover: 6.688234059068294
Capitalized R&D asset: 97115550.23802115
ROCI (R&D-adjusted, %): 4.472863744974345
Rosenberg metric: 0.4840735832213672
FCF margin (%): 50.03231969817825
Revenue growth (%): 10.687299457381192
Rule of 40 score: 60.71961915555944
Financial ratios for BZ — quarterly report dated 2025-09-30
Total revenue: 303831601.1235955
Gross profit: 260602528.08988765
Operating income: 96506039.3258427
Net income: 113291151.68539326
Capital expenditures: 0
Operating cash flow: 164858848.31460673
Net tangible assets: 2680310393.258427
Owner earnings: 113291151.68539326
Return on net tangible assets (%): 4.22679223907595
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.2
P/E ratio: 31.309645402628476
Shares outstanding: 385186790
Book value: 2708607724.719101
P/B ratio: 3.299235044796585
Market cap (USD): 8936333528
Debt to equity: 0.008599664604420977
Current ratio: 4.184321785799879
Quick ratio: 4.183790207800199
Effective tax rate (%): 18.172790885903904
COGS to revenue (%): 14.22797130839683
R&D to revenue (%): 18.861118828298313
SG&A to revenue (%): 35.14975631922067
Free cash flow (dilution-adjusted): 164858848.31460673
Buyback yield (%): 0
Inventory turnover: 121.51243584682194
Receivables turnover: 51.25529545562242
Capitalized R&D asset: 115436510.98807168
ROCI (R&D-adjusted, %): 3.378720530993662
Rosenberg metric: 0.17676921879910965
FCF margin (%): 54.259941265143084
Revenue growth (%): 3.6167421295318065
Rule of 40 score: 57.87668339467489
Financial ratios for BZ — annual report dated 2025-12-31
Total revenue: 1181074000
Gross profit: 1004623571.4285715
Operating income: 352014428.5714286
Net income: 390762857.14285713
Capital expenditures: 9788428.57142857
Operating cash flow: 650338714.2857143
Depreciation & amortization: 116430142.85714285
Net tangible assets: 2846191142.857143
Owner earnings: 497404571.4285714
Return on net tangible assets (%): 17.47614782221734
Capex to operating income (%): 2.78068959024001
Buffett classification: The Great
Stock price: 20.38
P/E ratio: 20.08918359743213
Shares outstanding: 385186790
Book value: 2868719714.285714
P/B ratio: 2.73644955312569
Market cap (USD): 7850106780.2
Debt to equity: 0.007870260491514434
Current ratio: 4.656620059204897
Quick ratio: 4.656072162259852
Effective tax rate (%): 15.928475988465763
COGS to revenue (%): 14.93982837412631
R&D to revenue (%): 20.001178104480694
SG&A to revenue (%): 34.987671027749805
Free cash flow (dilution-adjusted): 503037285.7142857
Buyback yield (%): 0.2598654369538978
Retained earnings: 174889571.42857143
Inventory turnover: 515.721503131524
Receivables turnover: 44.35601695369923
Capitalized R&D asset: 474527553.37594026
ROCI (R&D-adjusted, %): 10.542973814718046
Rosenberg metric: 0.6706581316804641
FCF margin (%): 42.59151295467394
Revenue growth (%): 17.213414890294935
Rule of 40 score: 59.80492784496887
Financial ratios for BZ — quarterly report dated 2025-12-31
Total revenue: 296932428.5714286
Gross profit: 252775714.2857143
Operating income: 97998857.14285715
Net income: 99167857.14285715
Capital expenditures: 0
Operating cash flow: 189081571.42857143
Net tangible assets: 2846191142.857143
Owner earnings: 99167857.14285715
Return on net tangible assets (%): 3.4842304035598857
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.38
P/E ratio: 20.411849495231664
Shares outstanding: 385186790
Book value: 2868719714.285714
P/B ratio: 2.73644955312569
Market cap (USD): 7850106780.2
Debt to equity: 0.007870260491514434
Current ratio: 4.656620059204897
Quick ratio: 4.656072162259852
Effective tax rate (%): 19.208103259803234
COGS to revenue (%): 14.870963908575638
R&D to revenue (%): 19.531524007145446
SG&A to revenue (%): 31.014223053152545
Free cash flow (dilution-adjusted): 172064000
Buyback yield (%): 0
Retained earnings: 174889571.42857143
Inventory turnover: 129.05929018789143
Receivables turnover: 11.151494178872257
Capitalized R&D asset: 115539035.58919924
ROCI (R&D-adjusted, %): 3.273087935854154
Rosenberg metric: -0.13657921392316108
FCF margin (%): 57.94719048633959
Revenue growth (%): -2.2707225076829216
Rule of 40 score: 55.676467978656675
Financial ratios for CALN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.64835164835165
Shares outstanding: 6988453
Market cap (USD): 332988266.021978
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0